Ligelizumab for Chronic Spontaneous Urticaria
| 360 | Maurer, M.+, Giménez-Arnau, A. M., Sussman, G., Metz, M., Baker, D. R., Bauer, A., Bernstein, J. A., Brehler, R., Chu, C.-Y., Chung, W.-H., Danilycheva, I., Grattan, C., Hebert, J., Katelaris, C., Makris, M., Meshkova, R., Savic, S., Sinclair, R., Sitz, K., Staubach, P., Wedi, B., Löffler, J., Barve, A., Kobayashi, K., Hua, E., Severin, T., and Janocha, R.: Ligelizumab for chronic spontaneous urticaria. New Engl. J. Med. 2019: 381; 1321-1332. IF: 74.70 |
o.360